Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
This article was originally published at: https://arstechnica.com/health/2026/08/modernas-mrna-flu-...